ESO/LinkedIn
Jul 21, 2026, 03:19
Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
European Stroke Organisation shared on LinkedIn:
”In this ESOC 2026 TV Studio session, anchors Manon Kappelhof and Gerrit M. Große are joined by Urs Fischer and Johanna Ospel to reflect on the latest evidence surrounding medium and distal vessel occlusions and their implications for the future of stroke treatment.
Key themes include:
- Why improved reperfusion rates have not consistently translated into better clinical outcomes
- Whether specific patient subgroups, particularly those with more severe neurological deficits, may still benefit from endovascular treatment
- How future studies can optimise patient selection, outcome measures and trial design to better evaluate treatment effects”
Stay updated with Hemostasis Today.
-
Jul 21, 2026, 13:10Paolo Zamboni: Chronic Cerebrospinal Venous Insufficiency Hypothesis in Multiple Sclerosis
-
Jul 21, 2026, 13:05Danai Poutakidou։ The Diagnostic Pitfalls of Unexpected PT/INR Prolongation
-
Jul 21, 2026, 13:00Kefah Mokbel: Beyond Thromboprophylaxis – Enoxaparin’s Emerging Anticancer Signal
-
Jul 21, 2026, 12:56Emmanuel Velazquez-Alvarez: Bridging Innovation and Clinical Practice
-
Jul 21, 2026, 12:53Sandrine Bouteille: A Milestone Presentation at ISTH 2026
-
Jul 21, 2026, 12:40Kalled Musallam: A Comprehensive Review of Thalassemia
-
Jul 21, 2026, 12:34Jim Hoffman: Separating Evidence from Misinformation on Vaccine-Associated Thrombosis
-
Jul 21, 2026, 12:32Paolo Santini: Reduced-Dose DOACs in Cancer-Associated Thrombosis
-
Jul 21, 2026, 11:48A Century of VWD: Redefining Its Role Beyond Hemostasis